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Laminins are a family of basement membrane proteins with diverse roles in fundamental developmental processes such as epiblast polarization
and gastrulation, as well as in organ development and function. We have focused on the laminin α1 and α5 chains, the ancestral laminin α chains
required for development. To elucidate the unique functions of laminin α1 and α5 and their COOH-terminal LG domains, we have produced a
collection of laminin knockout and transgenic mice expressing full length and chimeric laminin α5/α1 chains. Crossing the transgenes onto the
Lama5−/− background generates “pseudo-knockins”, so called because endogenous laminin α5 is replaced by transgene-encoded proteins.
Expression of a chimera with the entire α5LG domain replaced by α1LG had minimal ameliorative effects on the defects observed in Lama5−/−
embryos. In contrast, high level expression of a chimera with only the α5LG3–5 tandem replaced by α1LG3–5 completely rescued defects in digit
septation, neural tube closure, placental labyrinth morphology, lung lobe septation, hair growth, and vascularization of kidney glomeruli. These
mice were viable for several months, but they developed a lethal nephrotic syndrome. Our results show that: (1) the laminin α5LG1–2 tandem
plays an essential role during development and harbors the great majority of the functionality of the α5LG domain; and (2) the α5LG3–5 tandem
serves as a novel determinant required for the kidney's glomerular filtration barrier to plasma protein.
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Laminins are components of all basement membranes
(BMs), specialized extracellular matrices found throughout
the bodies of vertebrates and invertebrates. Laminin's
functions have both structural and signal transduction
aspects, which stem from laminin's contribution to the
formation and stability of BMs, to the stability of cellularAbbreviations: BM, basement membrane; LG, laminin-type globular; GBM,
glomerular basement membrane; E, embryonic day; PBS, Ca2+ and Mg2+-free
phosphate-buffered saline; VEGF, vascular endothelial growth factor.
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doi:10.1016/j.ydbio.2006.04.463attachments to BMs, and to cytoskeletal rearrangements
mediated by engagement of cell surface receptors (Clark and
Brugge, 1995; Colognato et al., 1999; Henry and Campbell,
1996; Timpl, 1996; Yamada and Miyamoto, 1995; Yurch-
enco and O'Rear, 1994). All laminins are composed of three
subunits, designated α, β, and γ chains. Five α, four β, and
three γ chains have been identified, and 15 different laminin
heterotrimers have been found to be synthesized and
secreted by cells (Aumailley et al., 2005; Miner and
Yurchenco, 2004). Gene targeting and human disease gene
studies have demonstrated that laminin chains have specific
functions in vivo (Coles et al., 2006; Fukumoto et al., 2006;
Helbling-Leclerc et al., 1995; Miner and Yurchenco, 2004;
Miner et al., 2006; Nguyen et al., 2005; Nishimune et al.,
2004; Pulkkinen and Uitto, 1999; Scheele et al., 2005; Yang
et al., 2005). The existence of multiple chains generates not
only molecular but also structural and functional diversity of
BMs (Sanes et al., 1990).
266 Y. Kikkawa, J.H. Miner / Developmental Biology 296 (2006) 265–277In kidney, the glomerular BM (GBM) plays critical roles in
filtration and in maintenance of glomerular morphology (Miner,
2005). The GBM contains an atypical assortment of BM protein
isoforms, including laminin α5β2γ1 (laminin-521 in the new
nomenclature described in Aumailley et al., 2005; formerly
laminin-11) and collagen α3–α5(IV) (Miner, 1998; Miner,
1999). The importance of these components is demonstrated by
the fact that mutations in any one of the genes encoding
collagen α3–α5(IV) in humans, mice, and dogs cause Alport
syndrome, a hereditary glomerulonephritis. Furthermore, mice
and humans lacking laminin β2 exhibit congenital nephrotic
syndrome, as well as severe developmental defects at the
neuromuscular junction (Miner et al., 2006; Noakes et al.,
1995a,b; Zenker et al., 2004). We previously generated a
targeted mutation in Lama5 (Miner et al., 1998), the gene
encoding laminin α5, and found that glomerulogenesis fails in
Lama5−/− mice due to breakdown of the GBM (Miner and Li,
2000). This phenotype, together with the developmental defects
that lead to death of Lama5−/− fetuses (Miner et al., 1998),
have precluded studies of the role of laminin α5 in kidney
function and other postnatal processes.
Of the three laminin chain types, the five laminin α chains
share a large, laminin type globular (LG) domain at their C-
termini, which consists of five homologous domains (LG1–
LG5), each 180 to 200 amino acids. The LG domain belongs to a
superfamily and is also found in a number of other extracellular
matrix proteins, including perlecan and agrin (Timpl et al.,
2000). These LG domains contain binding sites for β1 integrins
and heparin, as well as for α-dystroglycan and the Lutheran
blood group glycoprotein in some isoforms (Kikkawa et al.,
2002; Suzuki et al., 2005; Talts and Timpl, 1999). The roles of
laminins in mediating developmental events and cellular
behavior are thought to result from the binding of the LG
domains to integrins, dystroglycan, Lutheran, and/or other
receptors. However, few functional studies of the laminin LG
domain in vivo have been carried out, yet such studies are crucial
to investigate functional differences among the lamininα chains.
We previously began to investigate the role of the laminin α5
LG domain by producing transgenic mice expressing altered
laminin α5 chains with either all or part of the α5 LG domain
replaced by the analogous segments of α1. One chimera,
designated Mr51, is composed of mouse laminin α5 domains
LN through the laminin coiled-coil (LCC) domain fused to the
human laminin α1LG; the second, designated Mr5G2, is
composed of α5 domains LN through LG2 fused to human
α1LG3–5 (Kikkawa et al., 2002). Five independent Mr51 lines
and one Mr5G2 line (called Mr5G2L in this study) were
produced and mated onto the Lama5−/− genetic background. In
kidney, transgene-derived protein restored integrity to the
GBM, and glomeruli became vascularized, but the capillaries
ballooned under the pressure of blood flow due to detachment
of mesangial cells from the GBM. This shows that the LG
domain of laminin α5 is required for glomerular maturation,
because mesangial cells use it to adhere to the GBM and
maintain capillary loop structure (Kikkawa et al., 2003).
Furthermore, the combined transgenic/knockout approach
allowed us to uncover a specific function for laminin α5 inembryogenesis that would not have been found through a
knockout approach alone.
In the present study, we report the production of an
additional, independent line of Mr5G2 transgenic mice that
express mRNA and protein more highly than the previously
reported line, and we present a detailed analysis of the effects of
the chimeric chains on Lama5−/− developmental phenotypes.
Surprisingly, high levels of Mr5G2 expressed on the Lama5−/−
background rescued the perinatal lethality, and the resulting
mice lived for several months. This shows that α5LG3–5 is not
required for viability. However, all the rescued mice manifested
nephrotic syndrome, indicating that α5LG3–5 is required for
the integrity of the glomerular filtration barrier.
Materials and methods
Chimeric laminin α chain transgenes
The chimera transgenes, designated Mr51 and Mr5G2, were constructed as
described (Kikkawa et al., 2002). We used human rather than mouse α1LG
domains because of the availability of antibodies specific for the human domain
(Virtanen et al., 2000); thus, transgene-derived proteins could be specifically
detected in transgenic mouse tissues. Both chimeric laminin cDNAs were cloned
into a modified version of the widely active expression vector miw, which
contains the Rous Sarcoma Virus LTR inserted into the chicken β-actin
promoter (Suemori et al., 1990).
Generation of knockout and transgenic mice
Production of Lama5 mutant mice and transgenic mice expressing a full-
length lamininα5 transgene or the chimeric laminin transgenes has been described
(Kikkawa et al., 2002, 2003; Miner et al., 1998; Moulson et al., 2001). In our
previous study, five independent Mr51 lines, all of which gave similar results, and
oneMr5G2 line were produced. Here, an additional Mr5G2 line was generated by
microinjection into the pronuclei of B6CBAF2/J single-celled embryos.
Production of recombinant laminins and Western analysis
Recombinant proteins were produced in human embryonic kidney cells
(HEK293; ATCC CRL-1573). Cells were transfected with a mouse laminin γ1
expression vector (pIREShyg2-based; BD Biosciences Clontech, Palo Alto, CA)
using Lipofectamine 2000 (Invitrogen, Carlsbad, CA), and stable clones were
selected using 400 μg/ml hygromycin (Invitrogen). A clone highly expressing
mouse laminin γ1 was transfected with a mouse laminin β1 expression vector
(pcDNA3.1Neo(+)-based; Invitrogen), and stable clones were selected using
800 μg/ml G418 (Sigma, St. Louis, MO). A clone highly expressing laminin γ1
and β1 was transfected with mouse laminin α5 or chimeric α chain expression
vectors (pdCNA3.1Zeo(+)-based; Invitrogen), and stable clones were selected
using 400 μg/ml Zeocin (Invitrogen, Carlsbad, CA). Isolated clones in 24-well
dishes were grown to confluency in DMEM containing 10% FBS and then
incubated in serum free DMEM for 4 days. The conditioned media were
harvested and clarified by centrifugation at 10,000 rpm for 20 min. Supernatants
were screened for expression of recombinant laminins by SDS-PAGE on 4%
nonreducing gels followed by immunoblotting on polyvinylidene difluoride
membranes. Membranes were probed with anti-laminin α5LN serum and then
goat anti-rabbit IgG antibody conjugated with horseradish peroxidase
(Amersham Biosciences, Piscataway, NJ). Bound antibodies were visualized
with ECLWestern blotting detection regents (Amersham Biosciences).
RNA purification and real-time PCR
Total RNA was isolated from E17.5 kidney using an RNeasy Micro Kit
(QIAGEN, Hilden, Germany). Genomic DNA was removed from total RNA
prior to cDNA synthesis using the RNase-Free DNase Set (QIAGEN). First-
strand cDNA synthesis was performed with random hexamers using SuperScript
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expression was determined by real-time PCR using SYBR Green Master Mix
(Applied Biosystems, Foster City, CA). To quantify the expression of the
transgenes, a cDNA fragment encoding human laminin α1LG5 was amplified
by RT-PCR using the following primers: 5′-GGCTACAAAGTCCAGTCA-
GATGTG-3′ (sense) and 5′-CAGGCATTTTTGCTTCACACCAGC-3′ (anti-
sense). GAPDH was used as an endogenous control to normalize for differences
in the amount of total RNA in each sample. The primers for GAPDH were: 5′-
TTGTCAGCAATGCATCCTGC-3′ (sense) and 5′-CCGTTCAGCTCTGG-
GATGAC-3′ (antisense). Thermocycler conditions included an initial hold at
50°C for 2 min, then 95°C for 10 min; this was followed by a 2-step PCR
program: 95°C for 15 s and 68°C for 30 s for 50 cycles. Data were collected and
quantitatively analyzed on an ABI Gene Amp 5700 Sequence Detection System
(Applied Biosystems, Foster City, CA). The mean value of the triplicates for
each sample was calculated and expressed as cycle threshold (CT). The amount
of gene expression was calculated as the difference (ΔCT) between the mean CT
value of the sample for the transgene and the mean CT value of that sample for
the GAPDH. Relative expression was calculated as the difference (ΔΔCT)
between the ΔCT values of the test sample and of the relative control sample.
Relative expression of transgenes was expressed as 2−ΔΔCT.
Antibodies
Monoclonal antibodies against human laminin α1LG4–5 (163DE4)
(Virtanen et al., 2000) was a gift from Dr. Ismo Virtanen (University of
Helsinki, Helsinki, Finland). Rabbit antibodies to laminin α2LG (Cheng et al.,
1997) and laminin α3β3γ2 (Marinkovich et al., 1992) were gifts from Drs. Peter
D. Yurchenco (Robert Wood Johnson Medical School, Piscataway, NJ) and M.
Peter Marinkovich (Stanford University, Stanford, CA), respectively. Rabbit
antibodies to laminin α1LN, laminin α4LEa, and laminin α5LN (Ettner et al.,
1998; Garbe et al., 2002; Sasaki et al., 2001) were gifts from Drs. Takako Sasaki
and the late Rupert Timpl (Max-Planck Institute, Martinsried, Germany).
Polyclonal antibodies to laminin-1 (Sanes et al., 1990) and agrin were gifts from
Dr. Joshua Sanes (Harvard University, Cambridge, MA). Rat monoclonal
antibodies MAB1914 to laminin γ1, MAB1946 to nidogen-1, and MAB1948 to
perlecan were purchased from Chemicon International (Temecula, CA). Goat
antibody to type IV collagen was purchased from Southern Biotechnology
Associates (Birmingham, AL). Rat monoclonal antibody MEC13.3 to platelet
endothelial cell adhesion molecule (PECAM) was purchased from Pharmingen
(San Diego, CA). Rat monoclonal antibody TROMA-1 to cytokeratin 8 was
purchased from Developmental Studies Hybridoma Bank (Iowa City, IA).
Rabbit antibody to podocin has been described (Roselli et al., 2002) and was a
gift from Corinne Antignac (Necker Hospital, Paris, France). Rabbit antibody to
mouse laminin α5LEb/L4b has been described (Miner et al., 1997).
Immunohistochemistry and electron microscopy
Mouse embryos and tissues were frozen whole by immersing in OCT
compound and freezing in 2-methylbutane cooled in a dry ice-ethanol bath.
Sections were cut at 7 μm in a cryostat, air-dried, blocked in 10% goat serum in
PBS, and incubated with primary antibody in PBS containing 1% BSA. Secondary
antibodies were conjugated to FITC (ICN, Costa Mesa, CA) or Cy3 (Chemicon,
Temecula, CA). Sections were mounted in 90% glycerol containing 0.1× PBS and
1 mg/ml p-phenylenediamine after washing in PBS. Fluorescent images were
captured with a Spot 2 CCD camera (Diagnostic Instruments, Sterling Heights, MI).
For semithin and ultrathin sectioning, embryonic kidneys were fixed in 4%
paraformaldehyde, 4% glutaraldehyde in 0.1 M cacodylate buffer and processed
as described (Noakes et al., 1995b). Two micron sections were cut with a glass
knife and stained with toluidine blue for light microscopy. Thin sections were
cut with a diamond knife and stained with lead citrate plus uranyl acetate for
transmission electron microscopy. Reagents were obtained from Polysciences
Inc. (Warrington, PA).
Alcian blue and Alizarin red staining
For skeletal analysis, fore- and hindlimbs were fixed overnight in 95%
ethanol and in acetone sequentially after removing skin and skeletal muscle.
After fixation, skeletons were incubated overnight in a staining solution of 20 ml60% ethanol, 5% acetic acid, 1 mg Alcian blue, and 3 mg Alizarin red. The
stained limbs were washed in 1% potassium hydroxide and 20% glycerol until
cleared, and stored in 100% glycerol.
Urinary protein analysis
Samples of urine were collected from deeply anesthetized mice immediately
before sacrifice. One μL was subjected to SDS PAGE on a 12% gel and stained
with Coomassie Brilliant blue.
Results
Production and characterization of transgenic mice expressing
altered laminin α5 chains
Laminin α5 deficient (Lama5−/−) mice die during embryo-
genesis with multiple developmental defects (Miner et al.,
1998). In our previous studies, we produced transgenic mice
expressing a full length mouse laminin α5 transgene (Mr5)
driven by the widely active regulatory element miw, which
contains a Rous Sarcoma Virus LTR and the chicken β-actin
promoter (Suemori et al., 1990). Full-length laminin α5 driven
by miw was observed widely in embryonic BMs in two
different lines, and this was sufficient to fully rescue all known
Lama5−/− embryonic defects. The resulting Lama5−/−; Mr5
mice are viable and fertile (Kikkawa et al., 2002, 2003; Miner et
al., 2004; Moulson et al., 2001). These results show that the
miw regulatory element directs expression of the transgene in a
manner sufficient to replace the missing endogenous laminin α5
wherever it is necessary.
To further investigate the specific functions of laminin α5
in development, we produced transgenic mice that express
chimeric laminin α5/α1 chains, also driven by miw. One
chimera, designated Mr51, is comprised of mouse laminin
α5 domains LN (formerly VI) through the coiled-coil
(formerly II/I) fused to the human laminin α1LG1–5
tandem. The second chimera, designated Mr5G2, contains
mouse α5 domains LN through LG2 fused to human
α1LG3–5 (Fig. 1A). The production of five independent
Mr51 lines and one Mr5G2 line was reported previously
(Kikkawa et al., 2003). Here, a second line of Mr5G2
transgenic mice was produced.
Each of the seven transgenes was found to be expressed, and
the chimeric proteins were deposited widely in BMs. Consistent
with this, the chimeras were found to be secreted appropriately
as trimers into the medium of transfected cells (Fig. 1B). In
vivo, all five Mr51 transgenes were expressed at similar levels
(based on immunohistochemistry—data not shown), but there
were clear differences in expression between the two Mr5G2
lines. Quantitative RT-PCR using primers specific for human
α1LG showed that the expression level in the second line
(hereafter called Mr5G2H) was 2.5 times higher than that of the
original line (Mr5G2L) (Fig. 1C). In addition, analysis of
Mr5G2 protein levels in multiple BMs by immunofluorescence
revealed significantly higher levels in the Mr5G2H line (Fig.
1D). In these side by side assays, Mr51 levels were comparable
to Mr5G2H levels and significantly higher than Mr5G2L levels
(Fig. 1D).
Fig. 1. Structure and expression of laminin α chains. (A) Schematics of full length and chimeric laminin chains. The LG domain of full-length laminin α5 (Mr5) was
swapped with human laminin α1LG to make the Mr51 chimera. The LG3–5 tandem only of Mr5 was swapped with human α1LG3–5 to make the Mr5G2 chimera.
The epitope of the anti-laminin α5 antibody is indicated (*). The small bar indicates the region of human laminin α1 amplified by RT-PCR in (C). LN, laminin N-
terminal domain; LCC, laminin coiled-coil domain. (B) Western analysis of recombinant laminins. Conditioned media of transfected HEK293 cells were subjected to
nonreducing SDS-PAGE, transferred onto membranes, and probed with anti-laminin α5. The position of nonreduced EHS laminin-1 (∼800 kDa) is indicated in the left
margin. The indicated α chains assembled with β and γ chains to form a trimer migrating at ∼800 kDa. The α and α′ bands may represent α chain monomers and/or
degradation products. (C) RNAwas extracted from E17.5 kidneys of Lama5−/− (Control) and Lama5−/−; Mr5G2 embryos of the two different lines for real-time PCR
analysis. Relative expression was calculated as described in Materials and methods. The expression level of Mr5G2L was set to 1.0; the expression level of Mr5G2H
was 2.5 times higher. (D) Immunofluorescence analysis of chimeric protein accumulation in E18.5 GBM (a–c, Lama5−/− background), E13.5 viscera (d–f, wild-type
background), and E13.5 distal limb ectoderm (g–i, wild-type background) shows that levels are consistently high in Mr51 andMr5G2H but relatively low in Mr5G2L.
S, lumen of stomach.
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chains
To determine the extent to which the chimeric proteins could
substitute for full length α5, which serves as a comparative
functional assessment of the α5 and α1 LG domains, each of the
seven transgenes (five Mr51, two Mr5G2) was bred onto the
Lama5−/− genetic background. No live Lama5−/−; Mr51 pups
from any of the five lines were obtained, indicating that they
died either before or shortly after birth. Lama5−/−; Mr51
animals were small (Fig. 2) and, as detailed below, exhibited the
same defects we initially reported for Lama5−/− embryos
(Miner et al., 1998), but the incidence of exencephaly was
reduced from 60% to less than 10%. The only other significant
difference observed was maintenance of the integrity of theGBM, and this was true for all five lines. However, the rescued
GBM was not sufficiently adherent for mesangial cells to
maintain glomerular capillary structure (Kikkawa et al., 2003).
These results show that the long arm of laminin α5 has only
limited function in the absence of the α5LG domain, for which
the α1LG domain is a poor substitute.
The Mr5G2L and Mr5G2H transgenes were also mated onto
the Lama5−/− background. Mr5G2L prevented exencephaly
and greatly improved the growth of Lama5−/− embryos (Fig.
2). However, syndactyly and glomerular capillary looping
defects were not rescued in Lama5−/−; Mr5G2L mice
((Kikkawa et al., 2003) and see below). Lama5−/−; Mr5G2L
mice were born alive and even suckled, but they never survived
to postnatal day 5 when tails were clipped for genotyping. These
mice likely died from kidney failure, as the ballooned
Fig. 2. Whole mount views of control and mutant/transgenic fetuses of the
indicated genotypes at E17.5. Transgenes expressing Mr51 or Mr5G2L were
separately mated onto the Lama5−/− genetic background. Lama5−/−; Mr51
embryos exhibited the same defects observed in Lama5−/− embryos, but the
incidence of exencephaly (shown for Lama5−/−) was reduced from 60% to less
than 10%. Mr5G2L rescued both exencephaly and growth defects. Bar, 10 mm.
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glomerular filtration. In contrast to these mice, Lama5−/−;
Mr5G2H mice (which express the transgene at higher levels)Fig. 3. Analysis of placental labyrinth vasculature at E17.5. Frozen sections of contro
label endogenous lamininα5 (green in panels A, B) and the chimeras (red in panels C,D
trophoblasts (red in panels I–L); and to laminin α1β1γ1 to label all BMs (green in pan
deposition of Mr5G2 (H) but not by Mr51 (G). Trophoblasts appeared to partially d
restored adhesion (L). Bar, 100 μm.were viable up to several months of age, but they exhibited
specific kidney filtration defects, as described in detail below.
Aside from this, the mice appeared to be normal, the males were
fertile, and all known Lama5−/− defects were rescued. These
results suggest that Mr5G2 transgene expression level is a
critical determinant of how well this chimeric laminin can
substitute for full length α5 and promote proper development
and organ function. It is also worth noting here that despite the
higher level of expression of Mr51 compared to Mr5G2L (Fig.
1D), Mr5G2L provides significantly more rescue. This indicates
that LG domain identity eclipses quantity as the more important
factor.
Consequences of chimeric α chain expression for Lama5−/−
placental dysmorphogenesis
As described above, Mr5G2 drastically improved the growth
of Lama5−/− embryos, but Mr51 did not. One possibility to
explain this is that they have different effects on development
and function of the placental labyrinth. In the placental
labyrinth, the fetal and maternal circulations come into close
proximity to exchange gases, nutrients, and wastes. In mice, the
labyrinth is composed primarily of trophoblasts and endothelial
cells, both derived from the embryo. The endothelial cells form
the vessels through which the embryonic blood circulates, and
they assemble a BM containing laminin α5. Three layers of
trophoblasts surround these vessels and line the adjacent spaces
through which the maternal blood flows (Watson and Cross,
2005).
To investigate the effects of Mr51 and Mr5G2 on the
placentopathy of Lama5−/− embryos, we used cell-specificl and mutant placenta (as indicated) were stained with antibody to laminin α5 to
); to PECAM to label endothelial cells (red in panels E–H); to TROMA-1 to label
els E–L). The reduced vascular complexity in the mutant (F) was normalized by
etach from endothelial BMs in the mutant (J), even with Mr51 (K), but Mr5G2
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Frozen sections of E17.5 control, Lama5−/−, Lama5−/−;
Mr51 and Lama5−/−; Mr5G2L placentas were stained with
antibodies to platelet endothelial cell adhesion molecule
(PECAM) and cytokeratin 8 (TROMA-1) to label endothelial
cells and trophoblasts, respectively, and doubly labeled with
an anti-laminin-1 polyclonal antibody to localize the BM that
separates the two cell types (Fig. 3). In addition, transmission
electron microscopy was used to view the fine structure of
the placental barrier (Fig. 4). In controls, the fetal
endothelium was highly complex and separated from
trophoblasts by the BM, to which both cell layers appeared
tightly adherent (Figs. 3E, I; 4A, E). In the Lama5−/−
placenta, the endothelial network was far less complex, and
the trophoblasts did not form stable adhesions to the BM,
resulting in detachment (Figs. 3F, J; 4B, F), as we previously
reported (Miner et al., 1998). Although Mr51 was incorpo-
rated into endothelial BMs in the labyrinth of Lama5−/−;
Mr51 placentas (Fig. 3C), its presence did not improve either
endothelial complexity or trophoblast adhesion to the BM
(Figs. 3G, K; 4G). Interestingly, despite the incorporation of
the chimeric laminin chain, which is sufficient to restore
integrity to the Lama5−/− GBM (Kikkawa et al., 2003), theFig. 4. Ultrastructural analysis of the placental barrier at E17.5. Electron
micrographs show control and mutant/transgenic placentas, as indicated. The
normally continuous BM (arrowheads in A–D) between trophoblasts (t) and
endothelial cells in control (A) was irregular in the Lama5−/− and Lama5−/−;
Mr51 mutants (B and C); Mr5G2 restored integrity to the BM (D). Trophoblasts
are normally tightly associated with the BM (E) but were frequently detached in
the Lama5−/− (F) and Lama5−/−; Mr51 (G) labyrinths. Mr5G2 restored
trophoblast adhesion to the BM (H).Lama5−/−; Mr51 endothelial BM was discontinuous and
irregular, similar to that in the Lama5−/− placenta (Figs. 4B,
C). In contrast, the presence of Mr5G2L (Fig. 3D) greatly
improved vascularization of the labyrinth and promoted
stable trophoblast adhesion to the BM, which had a normal
ultrastructure (Figs. 3H, L; 4D, H). Mr5G2H exhibited a
similar activity (data not shown). We conclude that
improvement in the health of Lama5−/−; Mr5G2 fetuses is
a direct consequence of restoration of placental architecture
and improved placental function. These data also suggest that
the laminin α5LG1–2 tandem contains a binding site
recognized by a trophoblast cell surface receptor.
Basement membrane composition of the Lama5−/− placenta
expressing chimeric α chains
Mutations in BM component genes, whether naturally
occurring or experimentally induced, have in many cases been
shown to lead to ectopic deposition of related components
(Kashtan and Kim, 1992; Miner and Sanes, 1996; Noakes et
al., 1995b; Patton et al., 1999; Patton et al., 1997). Such
ectopic deposition, sometimes referred to as compensation,
may serve to furnish some or all of the functions of the
missing or mutated component, but compensation can also
cause abnormal physiological responses. To determine the
molecular composition of the BMs containing chimeric
laminins, sections of E17.5 placenta were stained with
antibodies to laminins and other BM proteins. The BMs of
Lama5−/− and Lama5−/−; Mr51 placentas contained the
laminin α1, α2 and α4 chains (similar to control — Fig. 5),
but they nevertheless exhibited splits and discontinuities (Figs.
4B, C). This indicates that the LG domain of laminin α5 is
essential to maintain proper BM structure in the placental
labyrinth. The fact that the BM in Lama5−/−; Mr5G2
placentas had an apparently normal structure and function
narrows the requirement for α5 LG domain sequences to
the LG1–2 tandem. Immunostaining for other BM proteins,
such as agrin, type IV collagen, nidogen-1, and perlecan also
showed that there were no alterations caused by the absence of
laminin α5 or the presence of the chimeric chains (Fig. 6).
Accordingly, we conclude that the ectopic deposition of
extracellular matrix proteins was not responsible for rescue in
Lama5−/−; Mr5G2 placenta.
Role of the laminin α5 LG domain in lung development
The expression of laminin α5 in lung persists throughout
embryogenesis (Fig. 7E) and adulthood (Miner et al., 1997).
Although targeted mutation of Lama5 does not affect lung
branching morphogenesis or vasculogenesis, it prevents
assembly of the visceral pleura BM and lobar septation
(Nguyen et al., 2002). We therefore examined the effects of
chimeric α chain deposition on Lama5−/− lung. Both
chimeric α chains were assembled into the visceral pleura
BM (Figs. 7G, H), but in comparison with airway BMs,
deposition was weak. In normal mice (Fig. 7A), the right lung
is divided into four lobes: cranial, medial, caudal, and
Fig. 5. Expression of laminin α chains in the placenta. Sections of E17.5 control and mutant/transgenic placentas (as indicated) were stained with antibodies to laminin
α1, α2, α3, and α4 (as indicated). Laminin α1, α2, and α4 were detected in labyrinth BMs in all control and mutant placentas. Laminin α3 was undetectable in the
labyrinth. Scale bar, 100 μm.
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significant degree of incomplete septation (Fig. 7B), and
septation was similarly impaired in Lama5−/−; Mr51 lung
(Fig. 7C). On the other hand, Lama5−/−; Mr5G2L and
Lama5−/−; Mr5G2H lungs were properly septated despite the
low levels of pleural expression (Figs. 7D, H, and data not
shown), indicating that the α5LG1–2 tandem is sufficient to
mediate proper septation.
Analysis of digit septation in Lama5−/− limbs expressing
chimeric α chains
We previously showed that fore- and hindlimbs of Lama5−/−
embryos exhibit syndactyly (Miner et al., 1998). Here we
investigated digit septation in mutants expressing the chimeric α
chains both at the surface and internally by staining with Alcian
blue and alizarin red. AlthoughMr51 did not prevent syndactyly,
Mr5G2L slightly improved digit septation (Figs. 8C, G, D, H).
There was some distal digit fusion apparent in Lama5−/−;
Mr5G2L forelimbs, but there was complete separation of
cartilaginous tissue in the hindlimbs (Fig. 8H) despite the lack
of septation of the overlying skin (Fig. 8D). In contrast, the
Mr5G2H transgene completely rescued the septation defect
(data not shown). The straightforward interpretation of these
results is that α5LG1–2 in the ectodermal BM is necessary and
sufficient to support normal digit septation, but the low level ofMr5G2L expression (Fig. 1D) is inadequate to completely
rescue syndactyly.
Glomerular filtration barrier defects in Lama5−/−; Mr5G2H
mice
As discussed above, Lama5−/−; Mr5G2H mice were
viable. They were externally normal at birth and for ∼2
weeks afterwards but were a bit smaller than littermates at
the time of weaning. One male lived for 5 months and sired
two litters, but other Lama5−/−; Mr5G2H mice either died or
were sacrificed due to lethargic behavior at between 6 weeks
and 3 months of age. Urinalysis at > 1 month of age revealed
variably elevated protein to creatinine ratios (up to 152 g
protein/g creatinine), and some mice became overtly
edematous (Fig. 9A). SDS-PAGE analysis showed that the
major protein in mutant urine was albumin (Fig. 9B). Even
when urinary protein levels were high, analysis of blood
creatinine and urea nitrogen did not show the significantly
elevated levels that would indicate renal failure (data not
shown). This phenotype of edema with high levels of urinary
protein but normal blood creatinine and urea nitrogen levels
is reminiscent of the nephrotic syndrome and suggests a
breach in the glomerular filtration barrier, which normally
prevents most plasma protein from crossing into the urinary
space.
Fig. 6. Expression of non-laminin BM proteins in the placenta. Sections of E17.5 control and mutant/transgenic placentas (as indicated) were stained with antibodies to
agrin, collagen IV, nidogen-1, and perlecan (as indicated). Despite differences in vascular complexity, no differences in deposition of these proteins were detected.
Scale bar, 100 μm.
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To search for abnormalities in Lama5−/−; Mr5G2H
glomeruli that might correlate with the albuminuria, we
performed immunohistochemical and ultrastructural analyses.
Sections of control and Mr5G2H-rescued mutant kidneys were
stained with antibody to domain LEb/L4b of laminin α5,
which recognizes transgene-derived protein in Lama5−/−;
Mr5G2H tissues. The staining intensity of transgene-derived
protein in adult Lama5−/−; Mr5G2H glomeruli was slightly
higher than that in control (Fig. 10A). An anti-podocin
antibody, which stains only podocytes, reveals the morphology
of glomerular tufts; podocin staining showed that convolution
of capillaries in Lama5−/−; Mr5G2H glomerulus was similar
to that in control, although occasional mild capillary
distension was observed (Fig. 10A). Moreover, because mice
lacking laminin β2 exhibit nephrotic syndrome, we considered
the possibility that Lama5−/−; Mr5G2H mice might be
nephrotic due to reduced β2 levels as a consequence of
poor assembly with the chimera. However, anti-β2 staining
revealed no significant differences between control and mutant
GBMs at either E18.5 or P44 (Fig. 10A), suggesting that the
nephrotic syndrome is not caused by reduced accumulation of
laminin β2.
To further investigate the fine structure of the GBM and
adjacent cells, we used transmission electron microscopy tovisualize control and Lama5−/−; Mr5G2H glomeruli (Fig.
10B). In the control, the GBM, composed of a lamina densa and
two lamina lucidae, was clearly visible between podocytes and
endothelial cells. In the Lama5−/−; Mr5G2H glomerulus at 15
days of age, the lamina densa and lamina lucida on the podocyte
side were similar to those of control. However, the lamina lucida
of the endothelium was often expanded and diffuse. Moreover,
glomeruli of 45 day old Lama5−/−; Mr5G2H mice revealed a
greatly thickened lamina lucida at the endothelial aspect, with
occasional low density deposits (Fig. 10B). This may indicate
an abnormal endothelial response to the chimeric laminin or to
lack of the laminin α5LG3–5 tandem. Together, these results
clearly show that α5LG3–5 is crucial for proper GBM structure
and for proper glomerular filtration.
Discussion
Laminin α1 and α5 can be viewed as representing the two
ancestral laminin α chains, as they are likely the orthologues of
the only two α chains present in C. elegans and Drosophila.
While mutations that affect mouse laminin α2, α3, and α4 cause
tissue-restricted defects that are only apparent after birth, Lama1
and Lama5 mutants have severe developmental defects (Miner
et al., 2004). Because of the importance of laminin α1 and α5,
we have sought to define how sequence and structural differ-
ences between these two proteins reflect functional specificity.
Fig. 7. Lobar septation and visceral pleural BM formation in developing lung. (A–D) Photographs of E17.5 control and mutant/transgenic lungs, as indicated. The
ventral view of control lungs shows the right lung to be properly septated into four lobes (A). Lobar septation of the Lama5−/− right lung did not occur (B). Although
Lama5−/−; Mr51 lung was also not completely septated (C), Mr5G2 restored proper septation (D). (E–L) Frozen lung sections were stained with antibody to laminin
α5 to label endogenous laminin α5 (red in panels E, F) and chimeras (green in panels G, H). All BMs were labeled by anti-laminin γ1 antibody (I–L). Although the
visceral pleural BM (arrowheads) was discontinuous in Lama5−/− (J), both chimeric laminins were incorporated into and rescued the disrupted BM (G, H, K, L). h;
heart. Arrows in panels A, C, D indicate the separation between medial and caudal lobes.
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chimeric α5/α1 chains on the Lama5−/− genetic background;
we consider these mice to be “pseudo-knockins” in which the
chimera replaces the endogenous α5 protein. We have so far
restricted the engineered alterations to the COOH-terminal LG
domain, because different LG domains have been shown to bindFig. 8. Syndactyly in Lama5−/− embryos expressing chimeric laminins. (A–D) W
Forelimbs are on the left, hindlimbs on the right. Lama5−/− limbs exhibit syndactyly (
and alizarin red staining reveals cartilage and bone, respectively. In Lama5−/− limb, s
this (H), but Mr51 did not (G).cellular receptors with different specificities and affinities and
are therefore likely to be important for conferring functionality.
By analyzing the phenotypes of these mice, we have gained
novel insights into the functions of the α5LG domain.
The Mr51 chimera, which contains laminin α5 domains LN
through LCC fused to the complete human laminin α1LGhole mount views of E17.5 control and mutant/transgenic limbs, as indicated.
B); neither Mr51 nor Mr5G2L fully rescued the defect (C, D). (E–H) Alcian blue
ome distal cartilaginous components were fused (F). Mr5G2L prevented much of
Fig. 9. Lama5−/−; Mr5G2H mice develop nephrotic syndrome. (A) Whole
mount view of control and Lama5−/−; Mr5G2H mice at 4 months of age.
Although Mr5G2H rescued the Lama5−/− developmental defects, Lama5−/−;
Mr5G2H mice became edematous (A); the distended abdomen was full of fluid.
(B) SDS-PAGE analysis of 1 μL urine at 4 months of age. Lane 1, control; lane
2, Lama5−/−; Mr5G2H. The positions of molecular weight markers are
indicated. The presence of a large amount of albumin (∼66 kDa) in the mutant
demonstrates damage to the glomerular filtration barrier to protein, which causes
nephrotic syndrome and edema.
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for exencephaly and the breakdown of the GBM, as described in
our previous (Kikkawa et al., 2003) and present studies.
Placental morphogenesis, digit septation, lung lobe septation,
and embryonic growth were still significantly impaired in
Lama5−/−; Mr51 embryos (Figs. 2, 3, 7, 8). This indicates that
LG is the key domain of laminin α5 that mediates these crucial
developmental events and suggests that the α5 short and long
arms, which are present in Mr51, impart minimal α5-specific
functions.
To further dissect structure-specific functions of α5LG, we
generated transgenic mice expressing Mr5G2, which is com-
posed of laminin α5 domains LN through LG2 fused to human
laminin α1LG3–5 (Fig. 1). We studied two independent lines
expressing the transgene at low (Mr5G2L) and high (Mr5G2H)
levels. While this initially made interpretation of the phenotype
of Lama5−/−; Mr5G2 mice somewhat confusing, the two
differing levels of expression has actually provided additional
insights. Both lines were able to rescue exencephaly, placental
vascularization, and lung lobe septation, indicating the impor-tance of α5LG1–2 in the associated developmental processes.
Furthermore, both lines allowed survival of Lama5−/−
newborns, but Lama5−/−; Mr5G2L pups did not live for more
than a few days and exhibited syndactyly, albeit less severe than
Lama5−/− or Lama5−/−; Mr51 mice. We believe these pups die
from kidney failure, as the glomerular capillaries are distended
due to lack of mesangial cell adhesion to the GBM (Kikkawa et
al., 2003). In contrast, Lama5−/−; Mr5G2H mice appeared
normal (they did not exhibit the hair growth defects observed in
graftedLama5−/− skin (Li et al., 2003)), lived for up to 4months,
and did not show syndactyly or severe glomerular capillary
looping defects. Our interpretation of these conflicting results is
that the increased levels of the chimera in Lama5−/−; Mr5G2H
mice are able to sufficiently engage the relevant cellular receptors
on epithelial cells in the developing distal limb and onmesangial
cells in developing glomeruli to properly separate the digits and
maintain glomerular capillary loop structure, respectively. The
relevant receptor on mesangial cells is likely integrin α3β1, as
Itga3−/−mice exhibit variable distension of glomerular capillary
loops (Kreidberg et al., 1996). As discussed below, both α3 and
α6 integrins are likely involved in the limb (De Arcangelis et al.,
1999).
Despite the rescue of developmental defects, Lama5−/−;
Mr5G2H mice exhibited heavy proteinuria, edema, and a
greatly thickened GBM, primarily on the endothelial aspect,
that together likely lead to systemic pathophysiology and death.
The renal ultrastructural pathology indicates either a primary or
a secondary endothelial cell defect that eventually leads to
glomerular dysfunction. One possibility is that α5LG3–5,
which is missing from the Mr5G2 chimera, is normally
recognized by a receptor on glomerular endothelial cells
whose engagement provides a homeostatic signal but is not
required for adhesion. In the absence of this signal, overpro-
duction of matrix ensues, thus altering the nature of the
glomerular filtration barrier. Similarly, the presence of ectopic
α1LG3–5 in the GBM may activate an abnormal signaling
pathway in endothelial cells – perhaps via dystroglycan, which
binds to α1LG4–5 better than to α5LG4–5 (Yu and Talts,
2003) – thus leading to unrestricted matrix synthesis. However,
that Lama5+/−;Mr5G2H mice do not exhibit glomerular defects
argues against this dominant-negative type of mechanism.
Another possibility is that a soluble factor released by podocytes,
such as vascular endothelial growth factor (VEGF), normally
binds α5LG3–5 in the GBM and is thereby presented to the
endothelial cells; VEGF signaling might thus be disrupted in
Lama5−/−; Mr5G2H glomeruli. Indeed, manipulating the level
of VEGF secreted by podocytes can cause profound endothelial
and glomerular filtration defects (Eremina et al., 2003). Finally,
the lack of α5LG3–5 may change the intrinsic filtration
properties of the GBM and the glomerulus, in the same way
that removal of laminin β2 does in both mice and humans
(Noakes et al., 1995b; Zenker et al., 2004).
Regarding the differential effects of the chimeras on
placentation, the presence of α5LG1–2 led to a dramatic
improvement in vascularization of the placental labyrinth of
Lama5−/−; Mr5G2 embryos. (This was accompanied by greatly
improved embryonic growth, but at present the link is only
Fig. 10. Analysis of the glomerular barrier in Lama5−/−; Mr5G2H kidney. (A) Expression of laminin α5, Mr5G2, podocin, and laminin β2 in control and Lama5−/−;
Mr5G2H kidneys (as indicated) at ∼6 weeks (a–d, f, h) and at E18.5 (e, g). Frozen kidney sections were stained with antibody to laminin α5 to label endogenous
laminin α5 (a) andMr5G2 (c). Antibody to podocin was used to label podocytes and reveal the morphology of glomerular tufts (b and d). Antibody to laminin β2 (e–h)
reveals efficient accumulation in the GBM in all cases. (B) Ultrastructural analysis of the glomerular barrier. P15 control and both P15 and P45 Lama5−/−; Mr5G2H
glomeruli are shown, as indicated. In control, a uniform GBM with adjacent podocyte foot processes was present. At P15, Lama5−/−; Mr5G2H GBM was continuous
but slightly thinned in some areas. At P45, the lamina densa appeared normal, but the lamina lucida adjacent to endothelial cells was severely thickened, thus
separating the endothelium from the podocytes. Arrowheads, GBM lamina densa; arrows, occasional cytoplasmic processes in the thickened lamina lucida.
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the trophoblasts maintained adhesion to the BM (Figs. 3, 4).
Together with the fact that trophoblasts did not adhere to the
BM in Lama5−/−; Mr51 placentas, these results suggest that
trophoblasts bear an adhesion receptor for a site in α5LG1–2. It
will be of interest to investigate the nature of this receptor using
recombinant chimeric laminins; we have already found that
laminin α5 receptors, such as integrin α3β1, α6β1, α6β4, and
dystroglycan, are expressed by trophoblasts (YK and JHM,
unpublished data). However, placental dysmorphogenesis in the
absence of these receptors has not been reported (Georges-
Labouesse et al., 1996; Kreidberg et al., 1996; Murgia et al.,
1998; van der Neut et al., 1996). Thus, an unknown receptor
may mediate the adhesion of trophoblasts to laminin α5LG1–2.
Furthermore, several studies have shown that cell-surface
receptors are required for formation of BMs (Aumailley et al.,
2000; Henry and Campbell, 1998; Li et al., 2002). A receptor on
the trophoblast surface binding to α5LG1–2 may play BM
anchoring as well as organizing roles.
The Mr51 and Mr5G2 chimeras also exhibited differential
effects on neural tube closure, digit septation, and lung lobe
septation defects. Both chimeras significantly reduced the
incidence of exencephaly. However, only Mr5G2 was
beneficial for digit and lung lobe septation. This again
demonstrates the pivotal role that α5LG1–2 plays in these
developmental processes and underscores how important it is
to discover the mechanisms whereby cells interact with andrespond to it. Mice lacking the putative extracellular matrix
protein Fras1, which are a model for Fraser syndrome, also
have defects in lung lobe septation (Petrou et al., 2005); it will
be interesting to determine whether the defects in visceral
pleural BM in Fras1 and Lama5 mutant embryos are related.
That embryos lacking both integrin α3 and α6 also exhibit
syndactyly and impaired lung lobe septation indicate that they
are both likely involved as receptors for α5LG (De Arcangelis
et al., 1999). Consistent with this, it has been shown that α3 and
α6 integrins bind better to α5-containing than to α1-containing
laminins (Kikkawa et al., 2000; Nishiuchi et al., 2003).
Moreover, mice lacking integrin α3 or α6 exhibit normal lung
and limb development (Georges-Labouesse et al., 1996;
Kreidberg et al., 1996), suggesting that these integrins
compensate for each other in binding laminin α5. The presence
of α5LG1–2 in Mr5G2 may increase the affinity of binding by
integrin α3 and α6, which allows normal development to occur.
Interestingly, the integrin binding site in human α5LG has been
shown to require LG3 but not LG4–5 (Ido et al., 2004; Yu and
Talts, 2003), but those studies used α5LG fragments and
deletion mutants, whereas our chimeras are substitution mutants
bearing full-size LG domains. Thus, based on the rescue of
phenotypes, the combination of α5LG1–2 and α1LG3 in
Mr5G2H appears to be sufficient to mediate effective integrin
binding, adhesion, and signal transduction in ways that
α1LG1–3 (in Mr51) cannot. Further studies of integrin binding
to chimeric α chains should help elucidate how interactions
276 Y. Kikkawa, J.H. Miner / Developmental Biology 296 (2006) 265–277between laminin α5LG and specific receptors contribute to
diverse developmental processes.
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